Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Corsera Health

HQ: Boston, MA source · corserahealth.com ↗

Clinical Phase 1

Keywords: RNA therapeutics subcutaneous Hyperlipidemia COR-2003 COR-1004

Location: Boston, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

2Trials (company is sponsor)

Timeline

2026-10 Trial start Phase 1: A Study to Evaluate COR-2003 as Monotherapy and Co-Administered With COR-1004 in Adult Volunteers source ↗
Nov 28, 2025 Trial start Phase 1: A Study to Evaluate COR-1004 in Adult Volunteers. source ↗

Upcoming milestones

2026-10 (ESTIMATED) · Phase 1 · A Study to Evaluate COR-1004 in Adult Volunteers. · NCT07229118
2027-08 (ESTIMATED) · Phase 1 · A Study to Evaluate COR-2003 as Monotherapy and Co-Administered With COR-1004 in Adult Volunteers · NCT07858019

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT07858019	A Study to Evaluate COR-2003 as Monotherapy and Co-Administered With COR-1004 in Adult Volunteers	Phase 1	Not yet recruiting	2026-10	2027-08 (estimated)
NCT07229118	A Study to Evaluate COR-1004 in Adult Volunteers.	Phase 1	Active, not recruiting	Nov 28, 2025	2026-10 (estimated)